Article in BMC endocrine disorders, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
2 citing papers in PubMed, 4 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
7 authors at 4 institutions in 1 country.
Zongming Wang *Department of Neurosurgery, Pituitary Tumor Center, the First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
Zize Feng *Department of Neurosurgery, Jiangmen Central Hospital, Guangdong, China.
Dimin ZhuDepartment of Neurosurgery, Pituitary Tumor Center, the First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
Xin WangDepartment of Histology and Embryology, School of Basic Medical Sciences, Guangdong Pharmaceutical University, Guangzhou, China.
Jinping ChenDepartment of Neurosurgery, Pituitary Tumor Center, the First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
Yonghong ZhuDepartment of Histology and Embryology, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, China. zhuyongh@mail.sysu.edu.cn.
Haijun WangDepartment of Neurosurgery, Pituitary Tumor Center, the First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China. wanghaij@mail.sysu.edu.cn.
Guangdong Pharmaceutical University · CNJiangmen Central Hospital · CNSun Yat-sen University · CNThe First Affiliated Hospital, Sun Yat-sen University · CN
Funding
Guangzhou Science and Technology Project No.202102021116Guangzhou Science and Technology Project No. 202201010307Medical Science and Technology Research Foundation of Guangdong Province, China No.2018558National Natural Science Foundation of China for Young Scholars No. 81802678Natural Science Foundation of Guangdong Province, China No.2018A030310107Sun Yat-sen University Clinical Research 5010 Program No. 2016008
6 · The paper itself
Abstract
backgroundWe assessed the value of positron emission tomography/computed tomography (PET/CT) with [
methodsNine consecutive patients with biochemical and clinical evidence of active recurrent tumor not detected by MRI and [
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Clinical application of combination [ · full record | OpenQuestion